Efficacy of greater occipital nerve block treatment for migraine and potential impact of patient positioning during procedure: Results of randomised controlled trial.
-
Published:2024-04
Issue:
Volume:239
Page:108210
-
ISSN:0303-8467
-
Container-title:Clinical Neurology and Neurosurgery
-
language:en
-
Short-container-title:Clinical Neurology and Neurosurgery
Author:
Vanderpol Jitka,
Kennedy Gina,
Ahmed Fayyaz,
Jonker LeonORCID
Reference22 articles.
1. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015;Vos;Lancet,2016
2. Headache disorders are third cause of disability worldwide;Steiner;J. Headache Pain.,2015
3. The epidemiology of primary headache disorders;Robbins;Semin. Neurol.,2010
4. Monoclonal antibodies for the prevention of migraine;Raffaelli;Expert Opin. Biol. Ther.,2019
5. Occipital nerve blocks and managed care: a review of the reviewers;Evans;Headache,2001